MedTrace Logo

Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles County

NCT02067507 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53414

Last updated 2019-10-25

No results posted yet for this study

Summary

The primary aim of the project is to increase human papillomavirus (HPV) vaccine receipt rates among low-income, ethnic minority adolescents (girls and boys 11-17 years of age) in Los Angeles County. We will accomplish this goal by implementing and rigorously evaluating interventions in multiple venues that serve our target population, including the Los Angeles County Department of Public Health (LACDPH) and two large Federally Qualified Health Centers (FQHCs).

Our hypotheses are:

Primary hypothesis:

1. The intervention group will have a higher rate of HPV vaccine initiation at follow-up compared to the control group.

Secondary hypothesis:
2. The intervention group will have higher vaccine completion rates (3 doses) at follow-up compared to the control group.

Conditions

  • Human Papilloma Virus Infection

Interventions

BEHAVIORAL

Tailored education and referral

LACDPH Site: 5-minute tailored educational messages and clinic referral for vaccine plus tailored small media

BEHAVIORAL

Staff training and patient reminders

AltaMed Health Services Corporation Site: (1) Health care provider training on the importance of HPV vaccination, strategies to appropriately frame the HPV vaccine conversation, and recommended processes and procedures for vaccine delivery; (2) Staff training on the importance of HPV vaccination, strategies to promote uptake of the vaccine, and recommended processes and procedures for vaccine delivery; (3) Patient reminders and provider cues for follow-up doses; and (4) Organizational strategies to improve processes for vaccine delivery, in addition to usual care activities

BEHAVIORAL

Clinic-level reminder systems

Northeast Valley Health Corporation Site: Three different clinic-level reminder systems, including a mailed letter, automated/robo telephone call, or text message reminder

Sponsors & Collaborators

Principal Investigators

  • Roshan Bastani, PhD · University of California, Los Angeles

  • Beth Glenn, PhD · University of California, Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
9 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2019-10-31
Completion
2019-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02067507 on ClinicalTrials.gov